封面
市场调查报告书
商品编码
1190957

冠状动脉血流储备分数 (FFR) 市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Fractional Flow Reserve Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

由于心血管疾病患病率上升和新兴产品趋势,预计冠状动脉血流储备分数 (FFR) 市场在预测期内的复合年增长率为 13.2%。

主要亮点

  • 心脏病是全世界死亡的主要原因。 根据世界卫生组织的数据,2017 年约有 1790 万人死于与心臟相关的疾病。 此外,世界上近四分之三的心血管疾病死亡发生在低收入和中等收入国家。
  • 此外,ACIST Medical Systems 在 2017 年发布了 FFR 系统“RXi Mini System”。 它旨在测量与血管造影互补的血压流量。 因此,这产生了对部分流量储备导丝和系统的需求。

冠状动脉血流储备分数 (FFR) 的市场趋势

冠脉血流储备(FFR)市场,导丝板块有望占据较大份额

  • 压力导丝在手术中用于确定是否有任何心臟血管或动脉需要手术。 它还可以作为到达病灶的导航工具。 血管造影术的增加及其独特的特性预计将对市场产生积极影响。
  • 根据《Deutsches Arzteblatt International》杂誌发表的一项研究,2019 年,德国每年进行约 80,000 例冠状动脉造影手术。 此外,在冠状动脉造影过程中引入压力导丝成功地了解了冠状动脉狭窄的血流动力学。

北美市场占有很大份额,预计在预测期内保持不变

由于人口老龄化和相关的心血管疾病增加,预计北美将占据冠状动脉血流储备分数 (FFR) 市场的很大份额。 根据美国疾病控制和预防中心的数据,2016 年约有 2620 万人被诊断出患有心脏病,使冠状动脉疾病成为美国被诊断出最多的心脏病。 根据美国心臟协会的数据,每年约有 720,000 人患心脏病。 因此,这些因素有望推动分流储备市场的增长。

冠状动脉血流储备分数 (FFR) 市场的竞争分析

市场是分散的,由几个主要参与者组成。 从市场份额的角度来看,一些主要参与者目前主导着市场。 每家公司为产品开发采取的战略举措预计将促进市场的增长。 例如,2019 年 Koninklijke Philips NV 推出了 IntraSight 介入应用平台,提供 iFR、FFR 和 IVUS 解决方案。 目前主导市场的公司包括 Opsens Medical、Abbott、Boston Scientific、GE Healthcare、Siemens Healthcare、Cathworks、Medis Medical Imaging System、Pie Medical Imaging BV、Heartflow Inc 和 Koninklijke Philips NV。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查先决条件
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 增加心血管疾病的负担
    • 产品进度
  • 市场製约因素
    • 严格的监管框架
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品类型
    • FFR 系统
    • 导丝
  • 按技术
    • 侵入性
    • 非侵入性
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Abbott
    • Boston Scientific
    • Cathworks
    • GE Healthcare
    • Heartflow Inc.
    • Koninklijke Philips NV
    • Medis Medical Imaging System
    • Opsens Medical
    • Pie Medical Imaging BV
    • Siemens Healthcare

第7章 市场机会今后动向

简介目录
Product Code: 68382

The fractional flow reserve market is expected to register a CAGR of 13.2% during the forecast period due to higher prevalence of cardiovascular diseases and emerging trends in product.

Key Highlights

  • Heart disease is the leading cause of death worldwide. According to the World Health Organization, in 2017, around 17.9 million people died due to heart related diseases. Moreover, almost ¾ of death globally occurring due to cardiovascular diseases is observed in low- and middle-income countries.
  • Furthermore, in 2017, ACIST Medical Systems introduced an FFR system, RXi Mini System. It is designed to measure blood pressure flow in complement with angiography. Hence, this arises the demand for fractional flow reserve guide-wires and system.

Fractional Flow Reserve Market Trends

Guidewires Segment is Expected to Hold a Major Market Share in the Fractional Flow Reserve Market

  • Pressure guide-wires are used in procedures to determine if any surgery is required in vessels or arteries of the heart. It also acts as a navigator tool to reach the lesion. The growing number of angiography and its unique characteristics are expected to influence positively on the market.
  • According to the study published by journal Deutsches Arzteblatt International, in 2019, around 80,000 procedures of coronary angiography are performed every year in Germany. Furthermore, when pressure guide-wire was introduced during coronary angiography, the hemodynamic of coronary stenosis was successfully determined.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the fractional flow reserve market due to the increasing geriatric population and associated cardiovascular diseases. According to the Center for Disease Control and Prevention, in 2016, approximately 26.2 million people were diagnosed with heart disease and coronary artery disease is the most diagnosed heart disease in United States. Also, according to the American Heart Association, the incidence rate of heart attack is around 720,000 annually. Hence, these factors are expected to propel the fractional flow reserve market growth.

Fractional Flow Reserve Market Competitive Analysis

The market is fragmented and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Strategic initiatives taken by companies to develop the product is expected to boost market growth. For instance, in 2019, Koninklijke Philips NV launched an IntraSight Interventional applications platform that offers iFR, FFR, and IVUS solution. Some of the companies that are currently dominating the market are Opsens Medical, Abbott, Boston Scientific, GE Healthcare, Siemens Healthcare, Cathworks, Medis Medical Imaging System, Pie Medical Imaging BV, Heartflow Inc., and Koninklijke Philips NV.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiovascular Diseases
    • 4.2.2 Advancments in Products
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 FFR System
    • 5.1.2 Guidewire
  • 5.2 By Technology
    • 5.2.1 Invasive
    • 5.2.2 Non-invasive
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Boston Scientific
    • 6.1.3 Cathworks
    • 6.1.4 GE Healthcare
    • 6.1.5 Heartflow Inc.
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Medis Medical Imaging System
    • 6.1.8 Opsens Medical
    • 6.1.9 Pie Medical Imaging BV
    • 6.1.10 Siemens Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS